FIRST AMENDMENT TO TRANSACTION AGREEMENTTransaction Agreement • November 6th, 2024 • Exscientia PLC • Biological products, (no disgnostic substances)
This first Amendment TO THE TRANSACTION AGREEMENT (this “Amendment”), dated as of November 5, 2024, is by and between Recursion Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Exscientia plc, a public limited company incorporated in England and Wales with registered number 13483814 (the “Company”).
